A Phase 4 interventional study of buccal swabs in Head and Neck Cancer, sponsored by Institut Sainte Catherine. Active, not recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-04.
Sponsored by Institut Sainte Catherine · Phase 4, Interventional, and Prevention
to characterise the impact of microbiota in radiotherapy efficacy
2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.
This study's planned enrollment of 100 is above the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.
Browse Head and Neck Neoplasms studies →Institut Sainte Catherine is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
-
buccal swabs for microbiota analysis before and after treatment
Other: buccal swabs
buccal swabs for microbiota analysis before and after radiotherapy
Microbiota
Analysis of buccal microbiota by 16SrRNA gene sequencing
Time frame: 2 years
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Sainte Catherine